metoprolol has been researched along with Germinoblastoma in 2 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this trial was to investigate long-term follow-up cardiotoxicity findings in patients treated with doxorubicin and concomitant metoprolol or enalapril 10 years earlier." | 9.30 | The Role of Metoprolol and Enalapril in the Prevention of Doxorubicin-induced Cardiotoxicity in Lymphoma Patients. ( Charpidou, A; Georgakopoulos, P; Karavidas, A; Kouvela, M; Kyriakidis, M; Mamalis, N; Perpinia, A; Zimeras, S, 2019) |
| " We investigated doxorubicin-induced clinical or subclinical cardiotoxicity in lymphoma patients after concomitant prophylactic therapy with metoprolol or enalapril or no concomitant treatment." | 9.14 | Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up. ( Ahimastos, A; Anagnostopoulos, N; Galanopoulos, A; Georgakopoulos, P; Georgiakodis, F; Karavidas, A; Kyriakidis, M; Marinakis, T; Matsakas, E; Roussou, P; Zimeras, S, 2010) |
| " The aim of this trial was to investigate long-term follow-up cardiotoxicity findings in patients treated with doxorubicin and concomitant metoprolol or enalapril 10 years earlier." | 5.30 | The Role of Metoprolol and Enalapril in the Prevention of Doxorubicin-induced Cardiotoxicity in Lymphoma Patients. ( Charpidou, A; Georgakopoulos, P; Karavidas, A; Kouvela, M; Kyriakidis, M; Mamalis, N; Perpinia, A; Zimeras, S, 2019) |
| " We investigated doxorubicin-induced clinical or subclinical cardiotoxicity in lymphoma patients after concomitant prophylactic therapy with metoprolol or enalapril or no concomitant treatment." | 5.14 | Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up. ( Ahimastos, A; Anagnostopoulos, N; Galanopoulos, A; Georgakopoulos, P; Georgiakodis, F; Karavidas, A; Kyriakidis, M; Marinakis, T; Matsakas, E; Roussou, P; Zimeras, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Georgakopoulos, P | 2 |
| Kyriakidis, M | 2 |
| Perpinia, A | 1 |
| Karavidas, A | 2 |
| Zimeras, S | 2 |
| Mamalis, N | 1 |
| Kouvela, M | 1 |
| Charpidou, A | 1 |
| Roussou, P | 1 |
| Matsakas, E | 1 |
| Anagnostopoulos, N | 1 |
| Marinakis, T | 1 |
| Galanopoulos, A | 1 |
| Georgiakodis, F | 1 |
| Ahimastos, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylactic Lisinopril to Prevent Anthracycline Induced Left Ventricular Systolic Dysfunction (PLAID) Study.[NCT03392740] | Phase 4 | 200 participants (Anticipated) | Interventional | 2018-03-15 | Not yet recruiting | ||
| A Prospective Randomized Placebo-controlled Study of the Effect of Eplerenone on Left Ventricular Diastolic Function in Women Receiving Anthracycline Therapy for Breast Cancer[NCT01708798] | Phase 2/Phase 3 | 44 participants (Actual) | Interventional | 2014-05-31 | Terminated (stopped due to Futility) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for metoprolol and Germinoblastoma
| Article | Year |
|---|---|
The Role of Metoprolol and Enalapril in the Prevention of Doxorubicin-induced Cardiotoxicity in Lymphoma Patients.
Topics: Adolescent; Anthracyclines; Antibiotics, Antineoplastic; Cardiotoxicity; Doxorubicin; Echocardiograp | 2019 |
Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antib | 2010 |
Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antib | 2010 |
Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antib | 2010 |
Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antib | 2010 |